For Neurocrine Biosciences, 2018 is shaping up as the year just about everything went right. The recent good news caps a dramatic recovery for the San Diego biotech company, that at one point came close to running out of money.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,